Precipitous and potentially fatal fall in blood pressure; myocardial ischemia
Concurrent use is absolutely contraindicated
Source: KDT 7e · p950
Organic nitrate vasodilator · Antianginal
Also known as Isosorbide-5-mononitrate, ISMN

KDIGO 2024 + manufacturer label
116 branded formulations and 18 fixed-dose combinations. Look up specific brands in the Drugs workspace.
Jan Aushadhi — generic available at GoI pharmacies
Converted to nitric oxide (NO) in vascular smooth muscle, activating guanylate cyclase → increased cGMP → dephosphorylation of myosin light chain → vasodilation. Preferentially dilates veins > arteries, reducing preload and myocardial oxygen demand.
Limited data; use only if clearly needed. Animal studies at high doses show adverse effects.
Excretion in breast milk unknown; use with caution. No adverse effects reported in nursing infants.
Precipitous and potentially fatal fall in blood pressure; myocardial ischemia
Concurrent use is absolutely contraindicated
Source: KDT 7e · p950
Precipitous and potentially fatal fall in blood pressure; myocardial ischemia
Concurrent use is absolutely contraindicated
Source: KDT 7e · p950
Profound and prolonged systemic hypotension, syncope, myocardial ischemia, and even death.
Concomitant use is absolutely contraindicated. A minimum of 12 hours should elapse between the last dose of avanafil and the administration of isosorbide mononitrate.
Source: DDInter
Potentiation of cGMP-mediated vasodilation → severe, potentially fatal hypotension.
Absolutely contraindicated. Sildenafil/vardenafil: avoid for 24h after nitrate. Tadalafil: avoid for 48h.
Source: Kimi deep-research + Cla
Riociguat (sGC stimulator) + nitrates → excessive hypotension.
Contraindicated. Use alternative antianginal if riociguat indicated.
Source: Kimi deep-research + Cla
Profound and prolonged systemic hypotension, syncope, myocardial ischemia, and even death.
Concomitant use is absolutely contraindicated. A minimum of 24 hours should elapse between the last dose of vardenafil and the administration of isosorbide mononitrate.
Source: DDInter
Significant orthostatic hypotension, dizziness, syncope, and reflex tachycardia.
Use with extreme caution. Start with low doses of both drugs and titrate slowly. Monitor blood pressure closely, especially during initiation and dose adjustments. Advise patients about symptoms of hypotension and how to manage them (e.g., rise slowly).
Additive hypotensive effects, potentially leading to severe hypotension, dizziness, syncope, and reflex tachycardia.
Avoid concomitant use if possible. If co-administration is necessary, monitor blood pressure closely and consider reducing the dose of one or both agents. Educate the patient about symptoms of hypotension.
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Additive vasodilation and hypotension; may precipitate syncope.
Advise patient to avoid or minimize alcohol while taking nitrates.
Source: Kimi deep-research + Cla
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Katzung, BNF·Verified: 2026-05-19 · House clinical team·Cockpit curated: 2026-05-19